×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Artificial insemination Market Trends

ID: MRFR/MED/0711-CR
90 Pages
Rahul Gotadki
February 2021

Artificial Insemination Market Size, Growth Research Report By Type (Intrauterine, Intracervical and Intratubal), End User (Hospitals & Clinics, Fertility Centre and Home-Based) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Competitor Industry Analysis and Trends Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Artificial insemination Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Artificial insemination Market

The Artificial Insemination market has witnessed significant growth in recent years, driven by advancements in reproductive technologies and a growing demand for efficient and controlled breeding in various animal species, including humans. Artificial insemination service from all over the world. The current market trend shows widespread adoption in many areas. Informing this expansion is the growing realization of the advantages positives that can be derived from AI in increasing fertility rates, ensuring genetic diversity, and consequently enhancing reproductive success as a whole. This vital trend that dictates the AI market is the constant development of the technological sphere. The newly emerging state-of-the-art innovations that are changing the way in which artificial insemination is undertaken include very accurate and effective AI methods that are driven by AI and also fusion of genetic screening tools. The demand for the AI services in the market livestock and agricultural is rising. An increasing number of farmers and breeders have been resorting to AI in order to establish effective breeding programs which are characterized by enhanced genetics, reduced disease vulnerability as well as increased productivity levels in both livestock and crops. In the area of reproduction, the human sphere in particular, AI is now the central figure. More couples are adopting artificial insemination as an acceptable solution in dealing with infertility issues due to increasing acceptance of AI approaches in the market. Transciention of found gender glass ceiling varies gender across the globe, due to this found effort in shadows of its National culture. Every marker trend is inclined towards low-cost alternatives in artificial insemination methods. It also encompasses the adoption of frozen semen, which improves the convenience of storage, transportation and widespread reach, thus the general accessibility of AI services. It is though the regulatory scene is changing to suit the rising numbers of artificial insemination within the society. Governments and regulatory bodies understand the need for regulations and frameworks to govern the usage of animal as well as human reproductive technology. The market is reporting a rapid increase in investments from both the public and private sectors which has been catalyzing research and developments in artificial insemination technologies. The trend towards partnership between research institutions, biotechnology companies as well as agricultural units is propping up the evolution of pioneering AI solutions. Although positive trends are evident, challenges are present which include ethical issues, need for holistic data governance policies, and knowledge of the need to address the public’s lack of confidence. A greater demand to reduce the environmental consequences of conventional reproduction methods gives rise to the use of AI as an alternative. The AI technology helps to minimise the need for large-scale breeding facilities operating with reduced impact on the ecological footprint making it market compliant to global initiatives. Market trends emphasize consumer education. After understanding the advantages and security of artificial insemination, the market is expected to garners substantial acceptance and demand in livestock farming as well as men and women with the fertility disorders. Looking ahead, the artificial insemination market is poised for continued growth. As technology continues to advance, regulatory frameworks mature, and public perception evolves, artificial insemination is expected to become an integral part of modern reproductive practices across various industries.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the study period of the artificial insemination market report?

The artificial insemination market forecast period is 2025 - 2035

What is the artificial insemination Market Growth rate?

The market is expected to register a CAGR of 9.68% over the next 10 years, according to artificial insemination market research.

Which region has the highest market growth rate?

Asia-Pacific is expected to register the highest CAGR during 2024 - 2035

Which region has the largest share of the market?

Europe held the largest share in 2021

What is the expected artificial insemination market size by 2032?

The market size is expected to be USD 9.2 billion by 2032.

Who are the key players in the market?

Vitrolife AB, Genea Limited, Rinovum Women's Health, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical are the major companies operating in the market.

Market Summary

The Global Artificial Insemination Market is projected to grow from 4.3 USD Billion in 2024 to 11.9 USD Billion by 2035.

Key Market Trends & Highlights

Global Artificial Insemination Key Trends and Highlights

  • The market is expected to experience a compound annual growth rate (CAGR) of 9.68 percent from 2025 to 2035. By 2035, the market valuation is anticipated to reach 11.9 USD Billion, indicating robust growth potential. In 2024, the market is valued at 4.3 USD Billion, reflecting the increasing demand for artificial insemination services. Growing adoption of advanced reproductive technologies due to rising infertility rates is a major market driver.

Market Size & Forecast

2024 Market Size 4.3 (USD Billion)
2035 Market Size 11.9 (USD Billion)
CAGR (2025-2035) 9.68%
Largest Regional Market Share in 2024 latin_america)

Major Players

<p><a href="https://www.vitrolife.com/ivf-journey/fertilisation-ivf--icsi/">Vitrolife AB</a>, Genea Limited, Rinovum Women's Health, Pride Angel, Hi-tech Solutions, <a href="https://kitazato-ivf.com/iui-embryo-transfer-catheters/intrauterine-insemination-catheter/">Kitazato Corporation</a>, Fujifilm Irvine Scientific, Rocket Medical</p>

Market Trends

Rising infertility rates and increased awareness among individuals about alternative reproductive treatments are two major factors influencing the market. Furthermore, governments in many countries have legalized same-sex marriage and provided insurance coverage to civil unions for artificial insemination procedures, fueling the market growth. Aside from that, the growing  population and increasing demand for animal-based protein drive the demand for artificial insemination in domestic livestock animals. Improving veterinary services and rising animal healthcare expenditure drive market growth. Furthermore, the leading players are forming strategic alliances to expand their portfolio of animal genetics and strengthen their position in various markets.

 

Artificial insemination Market Market Drivers

Increasing Demand for Livestock Production

The Global Artificial Insemination Market Industry experiences a notable surge in demand due to the increasing need for livestock production. As global populations rise, the demand for meat and dairy products escalates, prompting farmers to enhance productivity. Artificial insemination Market allows for the rapid genetic improvement of livestock, leading to healthier and more productive animals. This method is particularly advantageous in regions where traditional breeding practices are insufficient. By 2024, the market is projected to reach 4.3 USD Billion, reflecting the growing reliance on advanced reproductive technologies to meet food security challenges.

Market Segment Insights

Artificial Insemination Type Insights

<p>The market segments of artificial insemination, based on type, is intrauterine, intracervical, and intratubal. The intrauterine segment is expected exhibit a rapid CAGR and hold the largest market share in the artificial insemination market growth in 2021. This insemination method is the most used to treat infertility because it produces the highest pregnancy rate. It is also a non-invasive procedure. During the washing process, prostaglandins, pathogenic agents, antigenic proteins, nonmotile spermatozoa, immature germ cells, and other contaminants are removed, resulting in high-quality sperm.</p>

<p>These are the primary benefits that will drive the intrauterine segment's growth in the &nbsp;market during the forecast period. The intravaginal portion is expected to be the second largest (IVI). IVI can be performed in a fertility clinic or home, which is especially beneficial for surrogacy and donor insemination.</p>

<p>Artificial Insemination</p>

<p>Artificial Insemination End-User Insights</p>

<p>The artificial insemination market segmentation, by type, is hospitals &amp; clinics, fertility centers, and home-based. The fertility center segment is expected to have the largest market share in 2021 and to register the fastest CAGR during the forecast period. Fertility clinics are implementing various strategies to increase customer awareness and knowledge about available treatments and solutions for</p>

Get more detailed insights about Artificial Insemination Market Research Report - Global Forecast till 2035

Regional Insights

Key Companies in the Artificial insemination Market market include

Industry Developments

  • Q2 2024: CooperSurgical Launches New ARTlab™ Laboratory Management Platform for Fertility Clinics CooperSurgical announced the launch of ARTlab™, a new laboratory management platform designed to streamline workflows and improve data management in fertility clinics, supporting artificial insemination and other assisted reproductive technologies.
  • Q2 2024: Hamilton Thorne Announces Acquisition of IVFtech ApS Hamilton Thorne, a leading provider of precision instruments for fertility clinics, announced the acquisition of IVFtech ApS, a Danish manufacturer of laminar flow workstations and related products for artificial insemination and IVF laboratories.
  • Q2 2024: Fujifilm Irvine Scientific Opens New Manufacturing Facility in Tilburg, Netherlands Fujifilm Irvine Scientific opened a new manufacturing facility in the Netherlands to expand production of cell culture media used in artificial insemination and other assisted reproductive technologies, aiming to meet growing European demand.
  • Q3 2024: Vitrolife Appoints New CEO to Drive Growth in Fertility Solutions Vitrolife, a global leader in fertility treatment products including artificial insemination media, announced the appointment of a new CEO to accelerate its international expansion and product innovation.
  • Q3 2024: Cook Medical Launches Next-Generation Insemination Catheter Cook Medical introduced a next-generation insemination catheter designed to improve patient comfort and clinical outcomes in artificial insemination procedures.
  • Q4 2024: Genus plc Announces Strategic Partnership with CRV for Bovine Artificial Insemination Genus plc, a leader in animal genetics, announced a strategic partnership with CRV to jointly develop and distribute advanced bovine artificial insemination solutions in Europe.
  • Q4 2024: Pride Angel Launches Online Platform for Home Artificial Insemination Kits Pride Angel launched a new online platform offering home artificial insemination kits, aiming to increase accessibility and privacy for individuals and couples seeking fertility solutions.
  • Q1 2025: Medtronic Receives CE Mark for Automated Artificial Insemination Device Medtronic announced it has received CE Mark approval for its new automated artificial insemination device, enabling commercial launch in the European Union.
  • Q1 2025: Bayer AG Invests in Fertility Tech Startup Focused on AI-Driven Insemination Bayer AG announced a strategic investment in a fertility technology startup developing AI-driven solutions for optimizing artificial insemination outcomes.
  • Q2 2025: JLG Enterprises, Inc. Expands Manufacturing Capacity for Artificial Insemination Equipment JLG Enterprises, Inc. announced the expansion of its manufacturing facility to increase production of artificial insemination equipment, citing rising demand from fertility clinics and animal breeding centers.
  • Q2 2025: Hi-Tech Solutions Secures Series B Funding to Scale Artificial Insemination Technologies Hi-Tech Solutions, a provider of reproductive health technologies, secured Series B funding to accelerate the development and commercialization of its artificial insemination products.
  • Q2 2025: Cook Medical Receives FDA Clearance for New Artificial Insemination Syringe Cook Medical received FDA clearance for its new artificial insemination syringe, allowing for immediate commercialization in the United States.

Artificial Insemination Market Trends

Rising infertility rates and increased awareness among individuals about alternative reproductive treatments are two major factors influencing the market. Furthermore, governments in many countries have legalized same-sex marriage and provided insurance coverage to civil unions for artificial insemination procedures, fueling the market growth. Aside from that, the growing  population and increasing demand for animal-based protein drive the demand for artificial insemination in domestic livestock animals. Improving veterinary services and rising animal healthcare expenditure drive market growth. Furthermore, the leading players are forming strategic alliances to expand their portfolio of animal genetics and strengthen their position in various markets.

 Market Drivers

  •   Rising infertility issues in people to aid the  market growth

Infertility is one of the most serious and widespread issues affecting today's youth worldwide. The female preference for pregnancy and the gradual increase in the number of infertile couples who require pregnancy assistance can be attributed to market growth. The age of women, the quality of their eggs, and women in their late 30s are expected to increase demand for artificial insemination. Furthermore, infertility affects over 20 million women, according to the National Women's Health Resource Center.

Total fertility is expected to fall from 2.43 to 2.39 children per woman between 2020 and 2030, according to the 2017 United Nations World Population Prospects report. The rising prevalence of infertility among the  population drives the  market forward.

Market Restraints:

  • Most countries have strict regulations in place regarding who is eligible to receive fertility treatments, which is stifling market growth

Most countries' stringent regulations governing who is eligible to receive fertility treatments are impeding the growth of the  market. Italy and France, for example, prohibit lesbian couples and single women from using artificial insemination. Italy and Austria are among the countries that have banned all sperm and egg donations for IVF. Norway and Germany prohibit egg donation but permit sperm donation.

Market Opportunities:

  • Insurance companies covering artificial insemination treatment under medical coverage

Many insurance companies now cover artificial insemination as a medical procedure. These initiatives assist patients in fighting infertility and creating opportunities in the insurance industry. Moreover, Governments and international organizations develop policies and establish new institutions to improve medical connectivity, such as the Assisted Reproductive Technology (ART) Regulation Bill, the Nation Public Action Plan, the National Family Policy, and other initiatives. According to the UN Security Council, 84% of the country supports the policy that directly and indirectly affects the country's infertility.

Artificial Insemination Market Segment Insights

Artificial Insemination Type Insights

The market segments of artificial insemination, based on type, is intrauterine, intracervical, and intratubal. The intrauterine segment is expected exhibit a rapid CAGR and hold the largest market share in the artificial insemination market growth in 2021. This insemination method is the most used to treat infertility because it produces the highest pregnancy rate. It is also a non-invasive procedure. During the washing process, prostaglandins, pathogenic agents, antigenic proteins, nonmotile spermatozoa, immature germ cells, and other contaminants are removed, resulting in high-quality sperm.

These are the primary benefits that will drive the intrauterine segment's growth in the  market during the forecast period. The intravaginal portion is expected to be the second largest (IVI). IVI can be performed in a fertility clinic or home, which is especially beneficial for surrogacy and donor insemination.

Artificial Insemination End-User Insights

Future Outlook

Artificial insemination Market Future Outlook

<p>The Global Artificial Insemination Market is projected to grow at a 9.68% CAGR from 2024 to 2032, driven by advancements in reproductive technologies and increasing demand for livestock productivity.</p>

New opportunities lie in:

  • <p>Invest in AI-driven reproductive technologies to enhance success rates. Develop specialized training programs for veterinarians in artificial insemination techniques. Explore partnerships with biotech firms for innovative genetic solutions.</p>

<p>By 2035, the market is expected to exhibit robust growth, reflecting evolving agricultural practices and technological advancements.</p>

Market Segmentation

Artificial Insemination Type Outlook

  • Intrauterine
  • Intracervical
  • Intratubal

Artificial Insemination Region outlook

  • North America US Canada Mexico
  • US
  • Canada
  • Mexico
  • Europe UK Germany France Italy Spain Rest of Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific China India Japan Australia and New Zealand Rest of Asia-Pacific
  • China
  • India
  • Japan
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Rest of the World South America Middle East Africa
  • South America
  • Middle East
  • Africa
  • Artificial Insemination Market Forecast & Size:
  • Market Landscape and Trends:
  • Market Influencing Factors:
  • Impact of COVID-19:
  • Company Profiling:
  • Producers
  • Retailers
  • wholesalers
  • and distributors
  • Governments
  • associations
  • and industrial bodies
  • Pharma companies
  • Hospitals and Fertility centers

Artificial Insemination End Users Outlook

  • Hospitals & Clinics
  • Fertility Centre
  • Home-Based

Report Scope

Attribute/Metric Details
Market Size 2023 N/A (USD Billion)
Market Size 2024 4.3 (USD Billion)
Market Size 2035 11.9 (USD Billion)
Compound Annual Growth Rate (CAGR) 9.68 % (2025 - 2035)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year 2023
Market Forecast Period 2025 - 2035
Historical Data 2018-2022
Geographies Covered  North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Key Vendors Vitrolife AB, Genea Limited, Rinovum Women's Health, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical
Key Market Opportunities Insurance companies covering artificial insemination treatment under medical coverage
Key Market Drivers Rising infertility issues in people to aid the  market growth

FAQs

What is the study period of the artificial insemination market report?

The artificial insemination market forecast period is 2025 - 2035

What is the artificial insemination Market Growth rate?

The market is expected to register a CAGR of 9.68% over the next 10 years, according to artificial insemination market research.

Which region has the highest market growth rate?

Asia-Pacific is expected to register the highest CAGR during 2024 - 2035

Which region has the largest share of the market?

Europe held the largest share in 2021

What is the expected artificial insemination market size by 2032?

The market size is expected to be USD 9.2 billion by 2032.

Who are the key players in the market?

Vitrolife AB, Genea Limited, Rinovum Women's Health, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical are the major companies operating in the market.

  1. EXECUTIVE SUMMARY
  2. MARKET INTRODUCTION
    1. SCOPE OF THE STUDY 14
    2. RESEARCH OBJECTIVE 14
    3. MARKET STRUCTURE 14
    4. ASSUMPTIONS & LIMITATIONS 15
  3. RESEARCH METHODOLOGY
    1. DATA MINING 16
    2. SECONDARY RESEARCH 17
    3. PRIMARY RESEARCH 18
    4. BREAKDOWN OF PRIMARY RESPONDENTS 19
    5. FORECASTING TECHNIQUES 19
    6. RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
      1. BOTTOM-UP APPROACH 21
      2. TOP-DOWN APPROACH 21
    7. DATA TRIANGULATION 22
    8. VALIDATION 22
  4. MARKET DYNAMICS
    1. OVERVIEW 23
    2. DRIVERS 24
      1. GROWING RATE OF INFERTILITY IN THE WORLD 24
      2. CHANGING LIFESTYLE AMONG POPULATION 24
      3. RISE IN NHS FUNDED IN FERTILITY MARKET 24
    3. RESTRAINTS 25
      1. HIGH RISK OF CONCEIVING TWINS OR TRIPLETS AND OTHER COMPLICATIONS SUCH AS PREMATURE BIRTH OR MISCARRIAGE 25
    4. OPPORTUNITIES 26
      1. MEDICAL INSURANCE FOR THE COUPLES OF SAME SEXES 26
  5. MARKET FACTOR ANALYSIS
    1. VALUE CHAIN ANALYSIS 27
      1. CONSULTING DOCTOR FOR EVALUATION 27
      2. FERTILITY TESTING OF MALE & FEMALE 28
      3. DIAGNOSIS 28
      4. INSEMNINATION OF SPERM 28
    2. PORTER’S FIVE FORCES MODEL 29
      1. BARGAINING POWER OF SUPPLIERS 29
      2. BARGAINING POWER OF BUYERS 29
      3. THREAT OF NEW ENTRANTS 29
      4. THREAT OF SUBSTITUTES 30
      5. RIVALRY 30
    3. COVID-19 IMPACT ANALYSIS 30
      1. IMPACT ON GROWTH RATE 30
      2. IMPACT ON MAJOR PLAYERS 30
      3. IMPACT ON MAJOR REGIONS 30
  6. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE
    1. OVERVIEW 32
    2. INTRAUTERINE 33
    3. INTRACERVICAL 33
    4. INTRATUBAL 34
  7. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER
    1. OVERVIEW 35
    2. HOSPITALS & CLINICS 36
    3. FERTILITY CENTRE 36
    4. HOME-BASED 37
  8. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION
    1. OVERVIEW 38
    2. AMERICAS 39
      1. NORTH AMERICA 40
      2. LATIN AMERICA 43
    3. EUROPE 44
      1. WESTERN EUROPE 45
      2. EASTERN EUROPE 54
    4. ASIA-PACIFIC 55
      1. JAPAN 56
      2. CHINA 57
      3. INDIA 58
      4. AUSTRALIA 58
      5. SOUTH KOREA 59
      6. REST OF ASIA-PACIFIC 60
    5. MIDDLE EAST & AFRICA 61
      1. MIDDLE EAST 62
      2. AFRICA 63
  9. COMPETITIVE LANDSCAPE
    1. OVERVIEW 64
    2. COMPETITIVE BENCHMARKING 65
    3. COMPETITOR DASHBOARD 66
    4. MAJOR GROWTH STRATEGY IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67
    5. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67
    6. KEY DEVELOPMENT ANALYSIS 68
    7. KEY DEVELOPMENTS & GROWTH STRATEGIES 68
      1. PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68
      2. EXPANSIONS 68
  10. COMPANY PROFILES
    1. VITROLIFE AB 69
      1. COMPANY OVERVIEW 69
      2. FINANCIAL OVERVIEW 70
      3. PRODUCTS/SERVICES OFFERED 71
      4. KEY DEVELOPMENTS 71
      5. SWOT ANALYSIS 72
      6. KEY STRATEGIES 72
    2. GENEA LIMITED 73
      1. COMPANY OVERVIEW 73
      2. FINANCIAL OVERVIEW 73
      3. PRODUCTS/SERVICES OFFERED 73
      4. KEY DEVELOPMENTS 73
      5. SWOT ANALYSIS 74
      6. KEY STRATEGIES 74
    3. RINOVUM WOMEN’S HEALTH, LLC 75
      1. COMPANY OVERVIEW 75
      2. FINANCIAL OVERVIEW 75
      3. PRODUCTS/SERVICES OFFERED 75
      4. KEY DEVELOPMENTS 75
      5. SWOT ANALYSIS 76
      6. KEY STRATEGIES 76
    4. PRIDE ANGEL 77
      1. COMPANY OVERVIEW 77
      2. FINANCIAL OVERVIEW 77
      3. PRODUCTS/SERVICES OFFERED 77
      4. KEY DEVELOPMENTS 77
      5. SWOT ANALYSIS 78
      6. KEY STRATEGIES 78
    5. HI-TECH SOLUTIONS 79
      1. COMPANY OVERVIEW 79
      2. FINANCIAL OVERVIEW 79
      3. PRODUCTS/SERVICES OFFERED 79
      4. KEY DEVELOPMENTS 79
      5. SWOT ANALYSIS 80
      6. KEY STRATEGIES 80
    6. KITAZATO CORPORATION 81
      1. COMPANY OVERVIEW 81
      2. FINANCIAL OVERVIEW 81
      3. PRODUCTS/SERVICES OFFERED 81
      4. KEY DEVELOPMENTS 82
      5. SWOT ANALYSIS 82
      6. KEY STRATEGIES 82
    7. FUJIFILM IRVINE SCIENTIFIC, INC. 83
      1. COMPANY OVERVIEW 83
      2. FINANCIAL OVERVIEW 83
      3. PRODUCTS/SERVICES OFFERED 84
      4. KEY DEVELOPMENTS 84
      5. SWOT ANALYSIS 84
      6. KEY STRATEGIES 85
    8. ROCKET MEDICAL 86
      1. COMPANY OVERVIEW 86
      2. FINANCIAL OVERVIEW 86
      3. PRODUCTS/SERVICES OFFERED 87
      4. KEY DEVELOPMENTS 87
      5. SWOT ANALYSIS 87
      6. KEY STRATEGIES 87
  11. APPENDIX
    1. REFERENCES 88
    2. RELATED REPORTS 89
  12. LIST OF TABLES
  13. LIST OF ASSUMPTIONS & LIMITATIONS 15
  14. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
  15. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 32
  16. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRAUTERINE, BY REGION, 2022-2030 (USD MILLION) 33
  17. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRACERVICAL, BY REGION, 2022-2030 (USD MILLION) 34
  18. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR INTRATUBAL, BY REGION, 2022-2030 (USD MILLION) 34
  19. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 35
  20. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2022-2030 (USD MILLION) 36
  21. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR FERTILITY CENTRE, BY REGION, 2022-2030 (USD MILLION) 36
  22. GLOBAL ARTIFICIAL INSEMINATION MARKET, FOR HOME-BASED, BY REGION, 2022-2030 (USD MILLION) 37
  23. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 38
  24. AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 39
  25. AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 40
  26. AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 40
  27. NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 41
  28. NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 41
  29. NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 41
  30. US: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 41
  31. US: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 42
  32. CANADA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 42
  33. CANADA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 42
  34. LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 43
  35. LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 43
  36. EUROPE: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022-2030 (USD MILLION) 44
  37. EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 45
  38. EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 45
  39. WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 46
  40. WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 46
  41. WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 46
  42. GERMANY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 47
  43. GERMANY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 47
  44. FRANCE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 47
  45. FRANCE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 48
  46. UK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 48
  47. UK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 48
  48. ITALY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 49
  49. ITALY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 49
  50. SPAIN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 49
  51. SPAIN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 50
  52. BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 50
  53. BELGIUM: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 50
  54. SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 51
  55. SWEDEN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 51
  56. DENMARK: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 51
  57. DENMARK: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 52
  58. FINLAND: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 52
  59. FINLAND: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 52
  60. NORWAY: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 53
  61. NORWAY: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 53
  62. REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 53
  63. REST OF WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 54
  64. EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 54
  65. EASTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 54
  66. ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 55
  67. ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
  68. ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 56
  69. JAPAN: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
  70. JAPAN: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 57
  71. CHINA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 57
  72. CHINA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 57
  73. INDIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
  74. INDIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 58
  75. AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
  76. AUSTRALIA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 59
  77. SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
  78. SOUTH KOREA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 59
  79. REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
  80. REST OF ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 60
  81. MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 61
  82. MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
  83. MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 62
  84. MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
  85. MIDDLE EAST: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 63
  86. AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
  87. AFRICA: ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022-2030 (USD MILLION) 63
  88. MAJOR MANUFACTURERS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 65
  89. BENCHMARKING OF MAJOR COMPETITORS 65
  90. COMPETITOR DASHBOARD: GLOBAL ARTIFICIAL INSEMINATION MARKET 66
  91. MOST ACTIVE PLAYER IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67
  92. PARTNERSHIPS/COLLABORATIONS/AGREEMENTS 68
  93. EXPANSIONS 68
  94. VITROLIFE AB: PRODUCTS/SERVICES OFFERED 71
  95. VITROLIFE AB: KEY DEVELOPMENTS 71
  96. GENEA LIMITED: PRODUCTS/SERVICES OFFERED 73
  97. RINOVUM WOMEN’S HEALTH, LLC: PRODUCTS/SERVICES OFFERED 75
  98. RINOVUM WOMEN’S HEALTH, LLC: KEY DEVELOPMENTS 75
  99. PRIDE ANGEL: PRODUCTS/SERVICES OFFERED 77
  100. HI-TECH SOLUTIONS: PRODUCTS/SERVICES OFFERED 79
  101. KITAZATO CORPORATION: PRODUCTS/SERVICES OFFERED 81
  102. KITAZATO CORPORATION: KEY DEVELOPMENTS 82
  103. FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS/SERVICES OFFERED 84
  104. ROCKET MEDICAL: PRODUCTS/SERVICES OFFERED 87
  105. LIST OF FIGURES
  106. MARKET SYNOPSIS 13
  107. GLOBAL ARTIFICIAL INSEMINATION MARKET 14
  108. BOTTOM-UP AND TOP-DOWN APPROACHES 21
  109. MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ARTIFICIAL INSEMINATION MARKET 23
  110. DRIVER IMPACT ANALYSIS 25
  111. RESTRAINT IMPACT ANALYSIS 26
  112. VALUE CHAIN: GLOBAL ARTIFICIAL INSEMINATION MARKET 27
  113. PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ARTIFICIAL INSEMINATION MARKET 29
  114. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2022 AND 2030 (USD MILLION) 32
  115. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY END USER, 2022 AND 2030 (USD MILLION) 35
  116. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 AND 2030 (USD MILLION) 38
  117. AMERICAS: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 (%) 39
  118. NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 40
  119. EUROPE: ARTIFICIAL INSEMINATION MARKET, BY REGION, 2022 (%) 44
  120. WESTERN EUROPE: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 45
  121. ASIA-PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 55
  122. MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY COUNTRY, 2022 (%) 61
  123. MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL INSEMINATION MARKET 67
  124. GLOBAL ARTIFICIAL INSEMINATION MARKET: COMPETITIVE LANDSCAPE 68
  125. VITROLIFE AB: FINANCIAL OVERVIEW 70
  126. VITROLIFE AB: SWOT ANALYSIS 72
  127. GENEA LIMITED: SWOT ANALYSIS 74
  128. RINOVUM WOMEN’S HEALTH, LLC: SWOT ANALYSIS 76
  129. PRIDE ANGEL: SWOT ANALYSIS 78
  130. HI-TECH SOLUTIONS: SWOT ANALYSIS 80
  131. KITAZATO CORPORATION: SWOT ANALYSIS 82
  132. FUJIFILM IRVINE SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT 83
  133. FUJIFILM IRVINE SCIENTIFIC, INC.: SWOT ANALYSIS 84
  134. ROCKET MEDICAL: FINANCIAL OVERVIEW SNAPSHOT 86
  135. ROCKET MEDICAL: SWOT ANALYSIS 87

Artificial Insemination Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓